Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elmar Jaeckel

Showing results (11-20 of 142) with videos related to

Pageof 15
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2017
Budesonide in Autoimmune Hepatitis: The Right Drug at the Right Time for the Right PatientMichael P Manns, Elmar Jaeckel, Richard Taubert
Digestive Diseases (Basel, Switzerland)|October 19, 2012
Animal models for autoimmune liver disease--what is relevant for immune-mediated liver diseaseMatthias Hardtke-Wolenski, Richard Taubert, Elmar Jaeckel
Diabetes|December 14, 2004
Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetesElmar Jaeckel, Harald von Boehmer, Michael P Manns
Seminars in Liver Disease|August 14, 2009
The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1Tim O Lankisch, Elmar Jaeckel, Christian P Strassburg
Nature Immunology|September 21, 2004
Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetesElmar Jaeckel, Myra A Lipes, Harald von Boehmer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 15, 2017
Silymarin for Treatment of Nonalcoholic Steatohepatitis-A New Kid on the Block?Katharina L Hupa, Elmar Jaeckel, Michael P Manns
Journal of Hepatology|June 22, 2025
Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseasesElmar Jaeckel, Scott L Friedman, Michael Hudecek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
The future of autoimmune liver diseases - Understanding pathogenesis and improving morbidity and mortalityBastian Engel, Richard Taubert, Elmar Jaeckel, et al.
Seminars in Immunology|February 14, 2006
Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunityElmar Jaeckel, Karsten Kretschmer, Irina Apostolou, et al.
The Journal of Experimental Medicine|June 11, 2003
Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylaseElmar Jaeckel, Ludger Klein, Natalia Martin-Orozco, et al.
Pageof 15

Showing results (11-20 of 142) with videos related to

Sort By:
Pageof 15
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 13, 2017
Budesonide in Autoimmune Hepatitis: The Right Drug at the Right Time for the Right PatientMichael P Manns, Elmar Jaeckel, Richard Taubert
Digestive Diseases (Basel, Switzerland)|October 19, 2012
Animal models for autoimmune liver disease--what is relevant for immune-mediated liver diseaseMatthias Hardtke-Wolenski, Richard Taubert, Elmar Jaeckel
Diabetes|December 14, 2004
Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetesElmar Jaeckel, Harald von Boehmer, Michael P Manns
Seminars in Liver Disease|August 14, 2009
The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1Tim O Lankisch, Elmar Jaeckel, Christian P Strassburg
Nature Immunology|September 21, 2004
Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetesElmar Jaeckel, Myra A Lipes, Harald von Boehmer
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 15, 2017
Silymarin for Treatment of Nonalcoholic Steatohepatitis-A New Kid on the Block?Katharina L Hupa, Elmar Jaeckel, Michael P Manns
Journal of Hepatology|June 22, 2025
Chimeric antigen receptor (CAR) T-cell therapy: Engineering immune cells to treat liver diseasesElmar Jaeckel, Scott L Friedman, Michael Hudecek, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
The future of autoimmune liver diseases - Understanding pathogenesis and improving morbidity and mortalityBastian Engel, Richard Taubert, Elmar Jaeckel, et al.
Seminars in Immunology|February 14, 2006
Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunityElmar Jaeckel, Karsten Kretschmer, Irina Apostolou, et al.
The Journal of Experimental Medicine|June 11, 2003
Normal incidence of diabetes in NOD mice tolerant to glutamic acid decarboxylaseElmar Jaeckel, Ludger Klein, Natalia Martin-Orozco, et al.
Pageof 15